KAYS

distress 8/10 · high distress / dilution risk

$0.000%today-100% from 52w high

kayaholdings.com2 employeesBoca Raton, FLDrug Manufacturers - Specialty & Generic

Revenue

pre-revenue

Liquidity

$0M

Runway

0.0 yrs

Shares 1y

+1551%

Price & events

-99.5% over 6M

CatalystRating changeDilutionFinancingdashed = today

+0.0%

-97.1%

-98.5%

-99.3%

-99.5%

-99.2%

-99.5%

-99.9%

All

Overview

Market Cap: $137.29K
Volume: 0
52 Week Range: $0.00 – $0.06
Total Shares: 686.44M
Float Shares: 668.77M
% Held by Insiders: 2.77%
% Held by Institutions: 0.01%
Beta: 0.49

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 686,441,673 · 0 offerings/1y · 0 PIPEs

2024-12-16EFFECTshelf_effective
2024-12-11S-1/Ashelf_registration
2024-12-03S-1shelf_registration

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified